HEMOVEL^® is an oral treatment that helps to reduce the duration and severity of hemorrhoids and helps to relieve hemorrhoid symptoms, such as pain, swelling and bleeding.

Diosmin, the active ingredient in HEMOVEL^®, has been shown to significantly reduce overall hemorrhoid symptoms as early as the 2^nd day of treatment.

No. HEMOVEL^® is available over-the-counter at the pharmacy.

HEMOVEL^® is a 7-day treatment. You simply take 1 tablet three times a day for 4 days, then 1 tablet twice a day for 3 days. Consult a healthcare professional for use beyond 7 days.

You can find HEMOVEL^® at many pharmacies, retailers and online stores. Click here

HEMOVEL^® is generally well tolerated.  Possible side effects include abdominal pain, diarrhea and nausea. Some patients may experience headaches.² This product may not be right for you. Always read and follow the label.

HEMOVEL^® has been introduced in 2014 in Canada, but its active ingredient – diosmin 600 mg– has been trusted and used in Europe for over 20 years.

Consult a healthcare professional prior to use if you are pregnant or breastfeeding, or if you are taking any prescription medications. Do not use HEMOVEL^® if you are allergic to its medicinal ingredient (diosmin) or to any of the non-medicinal ingredients (magnesium stearate, microcrystalline cellulose, povidone, starch, water). Consult a healthcare professional if the condition worsens. In case of bleeding, consult a physician promptly. Do not take HEMOVEL^® if you are allergic to the medicinal ingredient (diosmin) or to any of its non-medicinal ingredients. This product may not be right for you. Always read and follow the label.

HEMOVEL^® is a 7-day treatment: 1 tablet three times a day for 4 days, then 1 tablet twice a day for 3 days. If you don’t take all the pills as recommended for a 7-day treatment, HEMOVEL^® might not be as effective as it should be.

If you forget to take a tablet, just take it as soon as you remember. Do not take a double dose to make up for the forgotten tablet.

No, there is no flavour added to the tablets.

Although taken systemically, HEMOVEL^® has proven to be well tolerated with few possible placebo-like side effects, like abdominal pain, diarrhea, nausea and headaches. This product may not be right for you. Always read and follow the label.

No, HEMOVEL^® does not contain any anesthetics agents. Each tablet contains 600 mg of diosmin.
An anesthetic agent, applied locally, will mainly relieve the pain temporarily, without treating or relieving the other symptoms.
Thanks to its mechanism of action HEMOVEL^® will treat the hemorrhoid at the source, relieve the pain, edema (swelling) and bleeding, along with reducing the severity and duration of symptoms.

As an oral treatment it treats hemorrhoids due to its properties: anti-inflammatory, antioxidant, venotonic and vasculoprotector (phlebotonic) and stimulates lymphatic circulation. Therefore, HEMOVEL^® helps to reduce the duration and severity of internal and external hemorrhoids from the "inside out”, working throughout the body at the source of the problem to relieve the symptoms.

HEMOVEL^® is generally well tolerated and has a placebo-like adverse event profile.
The few possible side effects include abdominal pain, diarrhea, nausea and headaches. This product may not be right for you. Always read and follow the label

Not enough is known about the use of diosmin during pregnancy and breastfeeding. Therefore the use of diosmin during pregnancy & lactation is not recommended (safety has not been established in large-scale well designed clinical trials).

Before starting a second treatment with HEMOVEL^®, the patient should consult a healthcare professional, particularly if hemorrhoid symptoms persist beyond 7 days, in order to exclude a more serious condition. In case of reoccurrence or incomplete relief of hemorrhoid symptoms, a second 7-day treatment cycle can be initiated upon the recommendations of a healthcare professional. There are no recommendations regarding the delay between two consecutive treatments or the number of repeat treatments with HEMOVEL^® for the intended use. The clinical judgment of the healthcare professional is warranted.